Corbus Pharmaceuticals Holdings, Inc. (CRBP)
USD 13.3
(-6.93%)
USD 13.3
(-6.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 881.7 Thousand | 3.93 Million | 36.14 Million | 4.82 Million |
| Cost of Revenue | 31.16 Million | 1.48 Million | 1.63 Million | 98.26 Thousand | 89.6 Thousand | 48.61 Million |
| Gross Profit | -31.16 Million | -1.48 Million | -757.52 Thousand | 3.83 Million | 36.05 Million | -43.79 Million |
| Operating Expenses | 13.9 Million | 34.83 Million | 56.87 Million | 126.74 Million | 113.24 Million | 61.56 Million |
| Selling, General and Administrative Expenses | 13.9 Million | 18.69 Million | 20.42 Million | 28.48 Million | 23.64 Million | 12.95 Million |
| Research and Development Expenses | 31.16 Million | 16.13 Million | 36.44 Million | 98.26 Million | 89.6 Million | 48.61 Million |
| Other Expenses | -31.16 Million | -48.77 Thousand | 11.89 Million | 13.27 Million | 4.58 Million | - |
| Cost and Expenses | 45.07 Million | 34.83 Million | 56.87 Million | 126.74 Million | 113.24 Million | 61.56 Million |
| Operating Income | -45.07 Million | -39.83 Million | -55.98 Million | -122.81 Million | -77.1 Million | -56.74 Million |
| Interest Expense | 2.92 Million | 2.13 Million | 1.83 Million | 1.02 Million | 19.02 Thousand | - |
| Income Tax Expense | - | 13.48 Million | -87.83 Thousand | 35.04 Thousand | -2.29 Million | 1.07 Million |
| Earnings before Tax | -44.6 Million | -42.34 Million | -45.64 Million | -111.26 Million | -71.45 Million | -55.67 Million |
| Net Income | -44.6 Million | -55.83 Million | -45.55 Million | -111.3 Million | -69.15 Million | -55.67 Million |
| Earnings Per Share Basic | -10.31 | -13.39 | -11.11 | -42.74 | -32.47 | -29.30 |
| Earnings Per Share Diluted | -10.31 | -13.39 | -11.11 | -42.74 | -32.47 | -29.30 |
| Weighted Average Shares Outstanding | 4.32 Million | 4.17 Million | 4.09 Million | 2.6 Million | 2.12 Million | 1.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.32 Million | 4.17 Million | 4.09 Million | 2.6 Million | 2.12 Million | 1.89 Million |
| Gross Margin | - | - | -0.86 | 0.98 | 1.00 | -9.08 |
| EBIT Margin | - | - | -63.82 | -31.01 | -2.13 | -11.79 |
| Profit Margin | - | - | -51.66 | -28.27 | -1.91 | -11.54 |
| EBITDA | -44.43 Million | -38.72 Million | -54.97 Million | -121.68 Million | -76.36 Million | -56.25 Million |
| Earnings Before Tax Margin | - | - | -63.50 | -31.19 | -2.13 | -11.77 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.34 Million | - | - | - |
| Cost of Revenue | 200 Thousand | 151.68 Thousand | 147.97 Thousand | 641 Thousand | 152.8 Thousand | 158.34 Thousand |
| Gross Profit | -200 Thousand | -151.68 Thousand | 1.2 Million | -641 Thousand | -152.8 Thousand | -158.34 Thousand |
| Operating Expenses | 10.78 Million | 9.47 Million | 9.95 Million | 44.43 Million | 9.48 Million | 8.18 Million |
| Selling, General and Administrative Expenses | 3.92 Million | 3.7 Million | 2.97 Million | - | 2.93 Million | 3.94 Million |
| Research and Development Expenses | 6.86 Million | 5.76 Million | 6.98 Million | - | 6.55 Million | 4.24 Million |
| Other Expenses | 695 Thousand | 2.9 Million | 2.75 Million | - | 217.54 Thousand | 182.65 Thousand |
| Cost and Expenses | 10.98 Million | 9.62 Million | 10.1 Million | 45.07 Million | 9.48 Million | 8.18 Million |
| Operating Income | -10.98 Million | -9.62 Million | -10.1 Million | -45.07 Million | -9.48 Million | -8.18 Million |
| Interest Expense | 652 Thousand | -177.01 Thousand | 707.01 Thousand | 2.92 Million | 763.35 Thousand | -775.58 Thousand |
| Income Tax Expense | - | 2.00 | 1.00 | - | 828.09 Thousand | 777.5 Thousand |
| Earnings before Tax | -9.99 Million | -6.89 Million | -8.02 Million | -44.6 Million | -10.05 Million | -8.78 Million |
| Net Income | -9.99 Million | -6.89 Million | -8.02 Million | -44.6 Million | -10.05 Million | -8.78 Million |
| Earnings Per Share Basic | -0.90 | -0.83 | -1.81 | - | -2.27 | -2.05 |
| Earnings Per Share Diluted | -0.90 | -0.83 | -1.81 | - | -2.27 | -2.05 |
| Weighted Average Shares Outstanding | 11.05 Million | 8.31 Million | 4.42 Million | 4.32 Million | 4.42 Million | 4.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.05 Million | 8.31 Million | 4.42 Million | 4.32 Million | 4.42 Million | 4.27 Million |
| Gross Margin | - | - | 0.89 | - | - | - |
| EBIT Margin | - | - | -7.38 | - | - | - |
| Profit Margin | - | - | -5.94 | - | - | - |
| EBITDA | -10.78 Million | -9.47 Million | -9.95 Million | - | -9.27 Million | -8.02 Million |
| Earnings Before Tax Margin | - | - | -7.49 | - | - | - |
CMAKY
SECURCRED
8072
2400
6988
AKR